MedPath

Cerclage for the Reduction of Extreme Preterm Birth in Twin Pregnancies With a Short Cervix or Dilatation

Not Applicable
Recruiting
Conditions
Preterm Birth
Interventions
Procedure: Vaginal cerclage
Registration Number
NCT05968794
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

The goal of this clinical trial is to assess the effectiveness of a cerclage in women with a twin pregnancy with a midpregnancy short cervix or cervical dilatation compared to standard treatment (no cerclage) in the prevention of extreme preterm birth \< 28 weeks of gestational age.

The main question it aims to answer is: What is the effectiveness of a cerclage in women with a twin pregnancy with a midpregnancy short cervix or cervical dilatation compared to standard treatment (no cerclage) in the prevention of extreme preterm birth \< 28 weeks of gestational age?

Participants will be randomly assigned to the intervention (cerclage) or comparison (no cerclage) group.

Detailed Description

Rationale: In the Netherlands, 250 women with a twin pregnancy deliver at \< 28 weeks per year, resulting in 157 perinatal deaths. A vaginal cerclage could be an effective surgical method to reduce cervical insufficiency and with that preterm birth, but the evidence regarding its effectiveness on extreme preterm birth and (long term) neonatal outcome is lacking.

Objective: To assess the effectiveness of a cerclage in women with a twin pregnancy with a midpregnancy short cervix or cervical dilatation compared to standard treatment (no cerclage) in the prevention of extreme preterm birth \< 28 weeks of gestational age.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: A vaginal cerclage is a minor and safe surgical procedure commonly performed in singleton pregnancies with a short cervix and a previous preterm birth in all the participating centers, thus there is experience in the participating hospitals. The results of this study will show whether a vaginal cerclage reduces extreme preterm birth in women with twin pregnancy and a short cervix, and its accompanying perinatal complications. If proven effective, the implementation of this intervention will have a huge impact on the lifelong health of these children and their families.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
238
Inclusion Criteria

Women (> 16 years of age) with a twin pregnancy and:

  • an asymptomatic short cervix at routine ultrasound investigation (below 24 weeks of gestation) OR
  • cervical dilatation (below 24 weeks of gestation)
Exclusion Criteria
  • Women with a mono-amniotic twin pregnancy
  • Women with twin pregnancy in which one or both children are diagnosed with a major structural, congenital or chromosomal abnormality that is likely to influence the composite adverse neonatal outcome.
  • Women with dilatation of the cervix and signs of clinical intra-uterine infection, defined by the presence of fever ≥ 38 degrees Celsius.
  • Women with overt symptoms of preterm labour at time of measurement of short cervix (regular contractions, PPROM, recurrent blood loss).
  • Women with a placenta previa, defined as a placenta position covering the internal ostium of the cervix.
  • Women who do not master the Dutch of English language and therefore not able to give written consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CerclageVaginal cerclageA vaginal cerclage is a short and minor surgical procedure performed under general or regional anesthesia. An unabsorbable suture is placed around/through the cervix to close the cervical canal and to increase its firmness, in order to reduce cervical insufficiency.
Primary Outcome Measures
NameTimeMethod
Rate of extreme preterm birth<28 weeks of gestation
Secondary Outcome Measures
NameTimeMethod
Number of neonates with bronchopulmonary dysplasiaUp to 3 months corrected age
Number of neonates with periventricular leucomalacia > grade 1Up to 3 months corrected age
Number of neonates with intraventricular hemorrhage > grade 2Up to 3 months corrected age
Days on ventilation supportUp to 3 months corrected age

Neonatal

Days in NICUUp to 3 months corrected age

Neonatal

Rate of maternal outcomesUp to 3 months corrected age

Sepsis, need for antibiotics, need to remove cerclage in operation room, mode of delivery (% caesarean delivery).

Rate of Premature rupture of membranesUp to 42 weeks of pregnancy
Gestational age at deliveryAt delivery
Rate of Preterm birth<24, <32, <34 and <37 weeks

Indicated and spontaneous

Adverse neonatal outcomeUp to 3 months corrected age

A composite for adverse neonatal outcome (including bronchopulmonary dysplasia, periventricular leucomalacia \> grade 1, intraventricular hemorrhage \> grade 2, necrotizing enterocolitis \> stage 2, retinopathy of prematurity \> stage 2, proven sepsis and perinatal death)

Number of neonates with necrotizing enterocolitis > stage 2Up to 3 months corrected age
Number of neonates with proven sepsisUp to 3 months corrected age
Maternal quality of life assessed by the 'European Quality of life 5-Dimension 5-Level' scoreUp to 3 months corrected age

The 'European Quality of life 5-Dimension 5-Level' score consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) that are rated using five levels (no problems (1), slight problems (2), moderate problems (3), severe problems (4), extreme problems (5)). A unique health state is defined by combining one level from each of the five dimensions. Each state is referred to by a 5-digit code, The best score is 11111 and the worst score is 55555.

Number of neonates with retinopathy of prematurity > stage 2Up to 3 months corrected age
Perinatal deathUp to 3 months corrected age

Trial Locations

Locations (13)

Radboud University Medical Center

🇳🇱

Nijmegen, Netherlands

Erasmus Medical Centre

🇳🇱

Rotterdam, Netherlands

University Medical Center Sint-Lucas Brugge

🇧🇪

Brugge, Belgium

University Medical Center Antwerpen

🇧🇪

Antwerpen, Belgium

University Medical Center Leuven

🇧🇪

Leuven, Belgium

University Medical Center Leiden

🇳🇱

Leiden, Netherlands

University Medical Center Gent

🇧🇪

Gent, Belgium

Hospital Oost-Limburg Genk

🇧🇪

Genk, Belgium

University Medical Center Amsterdam

🇳🇱

Amsterdam, Netherlands

University Medical Center Groningen

🇳🇱

Groningen, Netherlands

University Medical Center Maastricht

🇳🇱

Maastricht, Netherlands

Maxima Medical Centre

🇳🇱

Veldhoven, Netherlands

University Medical Center Utrecht

🇳🇱

Utrecht, Netherlands

© Copyright 2025. All Rights Reserved by MedPath